Your browser doesn't support javascript.
loading
Antiemetics in Children With Acute Gastroenteritis: A Meta-analysis.
Niño-Serna, Laura F; Acosta-Reyes, Jorge; Veroniki, Areti-Angeliki; Florez, Ivan D.
Affiliation
  • Niño-Serna LF; Department of Pediatrics, University of Antioquia, Medellín, Colombia.
  • Acosta-Reyes J; Hospital Pablo Tobón Uribe, Medellín, Colombia.
  • Veroniki AA; Department of Public Health, Universidad del Norte, Barranquilla, Colombia.
  • Florez ID; Department of Primary Education, School of Education, University of Ioannina, Ioannina, Greece.
Pediatrics ; 145(4)2020 04.
Article in En | MEDLINE | ID: mdl-32132152
ABSTRACT
CONTEXT Several antiemetics have been used in children with acute gastroenteritis. However, there is still controversy over their use.

OBJECTIVE:

To determine the effectiveness and safety of antiemetics for controlling vomiting in children with acute gastroenteritis. DATA SOURCES Medline, Embase, Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature, Latin America and the Caribbean Literature on Health Sciences, and gray literature, until December 2018. STUDY SELECTION We selected randomized clinical trials comparing metoclopramide, ondansetron, domperidone, dexamethasone, dimenhydrinate, and granisetron. DATA EXTRACTION Two reviewers independently screened abstracts and full texts, extracted the data, and assessed the risk of bias. We performed pairwise and network meta-analysis using the random-effects model.

RESULTS:

Twenty-four studies were included (3482 children). Ondansetron revealed the largest effect in comparison to placebo for cessation of vomiting (odds ratio = 0.28 [95% credible interval = 0.16 to 0.46]; quality of evidence high) and for hospitalization (odds ratio = 2.93 [95% credible interval = 1.69 to 6.18]; quality of evidence moderate). Ondansetron was the only intervention that reduced the need for intravenous rehydration and the number of vomiting episodes. When considering side effects, dimenhydrinate was the only intervention that was worse than placebo.

LIMITATIONS:

Most treatment comparisons had low- or very low-quality evidence, because of risk of biases and imprecise estimates.

CONCLUSIONS:

Ondansetron is the only intervention that revealed an effect on the cessation of vomiting, on preventing hospitalizations, and in reducing the need for intravenous rehydration. Ondansetron was also considered a safe intervention.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Gastroenteritis / Antiemetics Type of study: Clinical_trials / Diagnostic_studies / Systematic_reviews Limits: Child / Child, preschool / Humans / Infant Language: En Journal: Pediatrics Year: 2020 Document type: Article Affiliation country: Colombia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vomiting / Gastroenteritis / Antiemetics Type of study: Clinical_trials / Diagnostic_studies / Systematic_reviews Limits: Child / Child, preschool / Humans / Infant Language: En Journal: Pediatrics Year: 2020 Document type: Article Affiliation country: Colombia